Quantcast
Last updated on April 18, 2014 at 6:20 EDT

Latest International Society for Cellular Therapy Stories

2013-05-06 20:21:41

In the news release, BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting, issued 06-May-2013 by BioLife Solutions, Inc. over PR Newswire, we are advised by the company that the meeting date in the first paragraph should read "April 22 - 25" rather than "June 22 - 25." The complete, corrected release follows: BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting Continued Adoption of...

2013-05-06 08:29:33

Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications BOTHELL, Wash., May 6, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today provided an overview of the Company's participation at the 19(th) Annual Meeting of the International Society for...

2013-01-07 04:20:50

AMSTERDAM, January 7, 2013 /PRNewswire/ -- Official journal of the International Society for Cellular Therapy (ISCT) to be published by Elsevier beginning January 2013 Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that the International Society for Cellular Therapy (ISCT [http://www.celltherapysociety.org ]) has selected Elsevier to publish Cytotherapy: The...

2011-09-29 06:00:00

The interest of many insured US citizens was represented by participation of payor organizations including Anthem Blue Cross Blue Shield, LifeTrac and OptumHealth. VANCOUVER, Sept. 29, 2011 /PRNewswire/ - In keeping with its mission to drive the commercialization of cell therapy products and advance global patient access, ISCT hosted its second event this year in its Commercial Development Series, this time focusing on the timely issue of reimbursement for cell therapy and...

2011-04-13 08:15:00

ALLENDALE, N.J., April 13, 2011 /PRNewswire/ -- Progenitor Cell Therapy (PCT), a wholly owned subsidiary of NeoStem, Inc. (NYSE Amex: NBS) and an internationally recognized cell therapy services and development company, announced today that it has, once again, demonstrated compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration, and has earned FACT accreditation for its processing facilities through October 19, 2013...

2011-01-19 07:00:00

VANCOUVER, Jan. 19 /PRNewswire/ - In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease (PVD). PVD is a condition in which the arteries that carry blood to the arms or legs become narrowed or clogged. In a primary care population defined by age and common risk...

2010-09-29 07:30:00

EAST NORRITON, Pa., Sept. 29 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN) presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco. The presentation highlighted new results from Tengion's Neo-Kidney Augment(TM) development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes...

2010-08-16 05:00:00

VANCOUVER, Aug. 16 /PRNewswire/ - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development. The ISCT Industry Task Force (ITF), comprising these major corporations along with internationally renowned clinicians and academics in cell therapy...

2010-05-26 11:00:00

EAST NORRITON, Pa., May 26 /PRNewswire-FirstCall/ -- Tengion Inc. (Nasdaq: TNGN) today announced that its scientists have presented new research data in three podium presentations at the 16(th) Annual Meeting of the International Society for Cellular Therapy (ISCT) which was held May 23-26 in Philadelphia. These presentations highlighted key findings in Tengion's Neo-Urinary Conduit and Neo-Kidney Augment programs and provided further information about the company's work with various cell...